The estimated Net Worth of Ashish Khanna is at least $2.15 Milione dollars as of 2 December 2021. Mr. Khanna owns over 45,000 units of Aptinyx Inc stock worth over $25,622 and over the last 6 years he sold APTX stock worth over $0. In addition, he makes $2,124,730 as Chief Financial Officer e Chief Business Officer at Aptinyx Inc.
Sign up
Mr. Khanna APTX stock SEC Form 4 insiders trading
Ashish has made over 4 trades of the Aptinyx Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 45,000 units of APTX stock worth $101,700 on 2 December 2021.
The largest trade he's ever made was exercising 130,000 units of Aptinyx Inc stock on 17 May 2021 worth over $7,930. On average, Ashish trades about 17,527 units every 114 days since 2018. As of 2 December 2021 he still owns at least 420,040 units of Aptinyx Inc stock.
You can see the complete history of Mr. Khanna stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ashish Khanna biography
Ashish Khanna serves as Chief Financial Officer, Chief Business Officer of the Company. He was previously Vice President of Corporate Development at Naurex and managed its financing and transaction efforts between 2010 and 2015, culminating in the company's acquisition by Allergan plc. Prior to Naurex, Mr. Khanna served as Director of Business Development at Vanda Pharmaceuticals. He was formerly a member of the cardiology strategic marketing team at Cordis Corporation, a Johnson & Johnson company. Earlier, Mr. Khanna was a strategy consultant with the Palladium Group and with the Strategic Advisory Services practice of Ernst & Young (now Capgemini). He serves on the board of directors of the Illinois Biotechnology Innovation Organization. Mr. Khanna received a B.S. in finance and B.A.S. in systems engineering from the University of Pennsylvania, as well as an M.B.A. from the Wharton School.
What is the salary of Ashish Khanna?
As the Chief Financial Officer e Chief Business Officer of Aptinyx Inc, the total compensation of Ashish Khanna at Aptinyx Inc is $2,124,730. There are 1 executives at Aptinyx Inc getting paid more, with Norbert Riedel having the highest compensation of $5,635,420.
How old is Ashish Khanna?
Ashish Khanna is 44, he's been the Chief Financial Officer e Chief Business Officer of Aptinyx Inc since 2018. There are 9 older and no younger executives at Aptinyx Inc. The oldest executive at Aptinyx Inc is Elisha Gould, 63, who is the Independent Director.
What's Ashish Khanna's mailing address?
Ashish's mailing address filed with the SEC is C/O APTINYX INC., 909 DAVIS STREET SUITE 600, EVANSTON, IL, 60201.
Insiders trading at Aptinyx Inc
Over the last 6 years, insiders at Aptinyx Inc have traded over $0 worth of Aptinyx Inc stock and bought 10,337,357 units worth $55,328,087 . The most active insiders traders include Street Partners Llc Adams, Patrick G Enright e James N Topper. On average, Aptinyx Inc executives and independent directors trade stock every 35 days with the average trade being worth of $18,161. The most recent stock trade was executed by Joan W. Miller on 13 January 2022, trading 17,700 units of APTX stock currently worth $50,091.
What does Aptinyx Inc do?
welcome to our company page and thank you for your interest in aptinyx inc. aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the nmda receptor to enhance pathways involved with nerve cell communication. our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. at aptinyx, we remain committed and responsive to our employees. we offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. if you are interested in learning more, please visit our website at www.aptinyx.com.
What does Aptinyx Inc's logo look like?
Complete history of Mr. Khanna stock trades at Aptinyx Inc
Aptinyx Inc executives and stock owners
Aptinyx Inc executives and other stock owners filed with the SEC include:
-
Norbert Riedel,
President, Chief Executive Officer, Director -
Ashish Khanna,
Chief Financial Officer, Chief Business Officer -
Andrew Kidd,
Chief Operating Officer -
Dr. Norbert G. Riedel,
Exec. Chairman -
Dr. Andrew D. Kidd B.M. B.Ch., M.D.,
CEO, Pres & Director -
Ashish Khanna,
CFO & Chief Bus. Officer -
Henry Gosebruch,
Independent Director -
Rachel Sherman,
Independent Director -
Robert Hombach,
Independent Director -
Patrick Enright,
Independent Chairman of the Board -
Adam Koppel,
Independent Director -
Elisha Gould,
Independent Director -
Tim Noffke,
VP of Program Management & Chief of Staff -
Dr. Harald Murck M.D., Ph.D.,
VP of Clinical & Medical Affairs -
Patrick Flavin,
Sr. Mang. of Corp. Devel. & Investor Relations -
Dr. Kathryn King Ph.D.,
Sr. VP of Clinical & CMC Operations -
Molly Dir,
VP of HR -
Juan Estupinan,
VP of Fin. & Accounting and Controller -
Capital Life Sciences Inves...,
-
Gilmore Neil O'neill,
-
Terry P Gould,
-
Leaf Venture Management Iii...,
-
David Houck,
Chief Development Officer -
Torsten M. Madsen,
Chief Medical Officer -
James N Topper,
Director -
Life Sciences Viii, L.P.Fhm...,
-
Capital Partners Ii, Llc Ta...,
-
Wilbur H Gantz,
Director -
Joseph R. Moskal,
Chief Scientific Officer -
Street Partners Llc Adams,
10% owner -
Liam Ratcliffe,
Director -
Joan W. Miller,